Related Experiment Videos
[Reduced insulin effect in subclinical fatty liver]
1Abteilung für Klinische Chemie, Stoffwechselkrankheiten und Endokrinologie, Medizinische Universitätsklinik Tübingen, Tuebingen.
Deutsche Medizinische Wochenschrift (1946)
|April 15, 2004
Summary
Liver fat content, measured by proton MR spectroscopy, strongly correlates with whole-body insulin sensitivity in healthy individuals. This relationship persists even without clinical signs of fatty liver disease and is independent of overall body fat.
Area of Science:
- Metabolic Syndrome Research
- Hepatology
- Insulin Resistance Studies
Context:
- Liver steatosis is linked to impaired insulin action and metabolic syndrome.
- Assessing liver fat content is crucial for understanding metabolic health.
- Proton MR spectroscopy (¹H MRS) offers a non-invasive method to quantify liver fat.
Purpose:
- To investigate the correlation between liver fat content and whole-body insulin sensitivity in healthy subjects.
- To determine if liver fat is an independent predictor of insulin sensitivity.
- To explore this relationship in the absence of clinically apparent liver disease.
Summary:
- 21 non-diabetic subjects underwent euglycemic-hyperinsulinemic clamp tests and ¹H MRS for liver fat quantification.
- A strong correlation (r=0.7, p=0.001) was observed between percentage liver fat and insulin sensitivity index (ISI).
- Liver fat remained an independent determinant of ISI after adjusting for body fat percentage (p=0.01).
Impact:
- Liver fat content is a significant predictor of whole-body insulin sensitivity in healthy individuals.
- This finding highlights the role of hepatic steatosis in metabolic dysfunction, independent of overall adiposity.
- Suggests potential for ¹H MRS in early metabolic risk assessment.